Early cessation of calcineurin inhibitors is feasible post–haploidentical blood stem cell transplant: the ANZHIT 1 study

Haploidentical hematopoietic stem cell transplant (haplo-HSCT) using posttransplant cyclophosphamide (PTCy) is appropriate for those who lack matched donors. Most studies using PTCy have been retrospective making conclusions difficult. ANZHIT-1 was a phase 2 study conducted at 6 Australian allogenei...

Descripción completa

Detalles Bibliográficos
Autores principales: Moore, John, Hamad, Nada, Gottlieb, David, Bajel, Ashish, Ritchie, David, Yeung, David, Greenwood, Matthew, Purtill, Duncan, Tran, Steven, Solterbeck, Annie, Aarons, Donna, Kwan, John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society of Hematology 2023
Materias:
Clinical Trials and Observations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10514140/
https://www.ncbi.nlm.nih.gov/pubmed/37467011
http://dx.doi.org/10.1182/bloodadvances.2023009840

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10514140/
https://www.ncbi.nlm.nih.gov/pubmed/37467011
http://dx.doi.org/10.1182/bloodadvances.2023009840

Ejemplares similares